Service d'hématologie

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


792 publications

... | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | ...
2019
 
La TEVAR, un traitement durable des thrombi mobiles de l'aorte descendante?
Kohler Corinne, Wyss Thomas Rudolf, Alberio Lorenzo, Schmidli Jrg, Bhlmann Roman, 2019/10/09. Forum Médical Suisse ‒ Swiss Medical Forum.
[DOI][serval:BIB_3DAFCBE89B6C]
 
Systematic review and analysis of efficacy of recombinant factor IX products for prophylactic treatment of hemophilia B in comparison with rIX-FP.
Davis J., Yan S., Matsushita T., Alberio L., Bassett P., Santagostino E., 2019/10. Journal of medical economics, 22 (10) pp. 1014-1021. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4D4C4D16EF89]
 
Fungal spore contamination mimicking parasitic infection.
Blum S., Cairoli A., 2019/09/05. Blood, 134 (10) p. 841. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F8758958FE7F]
 
Acute Myeloid and Lymphoblastic Leukemia Cell Interactions with Endothelial Selectins: Critical Role of PSGL-1, CD44 and CD43.
Spertini C., Baïsse B., Bellone M., Gikic M., Smirnova T., Spertini O., 2019/08/27. Cancers, 11 (9). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_98FCF1C4A7F6]
Sinonasal relapses of a primary isolated extranodal NK/T-cell lymphoma of the testis.
Hallak B., Cairoli A., Bouayed S., Berthod G., 2019/08/13. BMJ case reports, 12 (8). Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8D46568F4071]
Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients.
Silzle T., Blum S., Schuler E., Kaivers J., Rudelius M., Hildebrandt B., Gattermann N., Haas R., Germing U., 2019/08/09. Blood cancer journal, 9 (8) p. 63. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E6110C1C36FA]
Diagnostic utility of the ISTH bleeding assessment tool in patients with suspected platelet function disorders.
Adler M., Kaufmann J., Alberio L., Nagler M., 2019/07. Journal of thrombosis and haemostasis, 17 (7) pp. 1104-1112. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AF13BB519DEE]
 
Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study.
Ghilardi G., Pabst T., Jeker B., Müller R., Cairoli A., Müller AMS, Bargetzi M., Hitz F., Baldomero H., Heim D. et al., 2019/07. Bone marrow transplantation, 54 (7) pp. 1029-1037. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E8AAF85209DE]
 
Contamination.
Bloch J., Blum S., 2019/04/04. Blood, 133 (14) p. 1612. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2E5D72CD5D2B]
Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial.
Poli E.C., Alberio L., Bauer-Doerries A., Marcucci C., Roumy A., Kirsch M., De Stefano E., Liaudet L., Schneider A.G., 2019/04/03. Critical care, 23 (1) p. 108. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CFD5FB3EFA6A]
Updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland.
Samaras P., Bargetzi M., Betticher D.C., Driessen C., Duchosal M.A., Heim D., Ketterer N., Lerch E., Matthes T., Mey U. et al., 2019/03/25. Swiss medical weekly, 149 pp. w20031. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2CA5CFE1DE61]
The NAD-Booster Nicotinamide Riboside Potently Stimulates Hematopoiesis through Increased Mitochondrial Clearance.
Vannini N., Campos V., Girotra M., Trachsel V., Rojas-Sutterlin S., Tratwal J., Ragusa S., Stefanidis E., Ryu D., Rainer P.Y. et al., 2019/03/07. Cell stem cell, 24 (3) pp. 405-418.e7. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9C9755E6E69D]
 
Agreement between activated partial thromboplastin time and anti-Xa activity in critically ill patients receiving therapeutic unfractionated heparin.
Ratano D., Alberio L., Delodder F., Faouzi M., Berger M.M., 2019/03. Thrombosis research, 175 pp. 53-58. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F476AFFE8F47]
 
Ten-year single-centre experience in fertility preservation of 459 patients suffering from acute leukaemia.
Noetzli J., Voruz S., Wunder D., Primi M.P., Spertini O., Blum S., 2019/03. British journal of haematology, 184 (6) pp. 969-973. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9AD1D6CC6F77]
 
Progrès récents et orientations futures de la thérapie avec cellules CAR-T en oncologie pédiatrique [Recent advances and future directions in CAR-T cell therapy in pediatric oncology]
Ceppi F., Renella R., Diezi M., Ansari M., Duchosal M.A., Arber C., Kandalaft L., Coukos G., Beck-Popovic M., 2019/01/09. Revue medicale suisse, 15 (N° 632-633) pp. 85-91. Peer-reviewed.
[Pmid][serval:BIB_556228939270]
Direct Oral Anticoagulant Drugs: On the Treatment of Cancer-Related Venous Thromboembolism and their Potential Anti-Neoplastic Effect.
Grandoni F., Alberio L., 2019/01/05. Cancers, 11 (1). Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_7E69AF0E3A41]
Immune Checkpoint Inhibition in Classical Hodgkin Lymphoma: From Early Achievements towards New Perspectives.
De Goycoechea D., Stalder G., Martins F., Duchosal M.A., 2019. Journal of oncology, 2019 p. 9513701. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_70A914BCFC4C]
2018
Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.
Adès L., Thomas X., Bresler A.G., Raffoux E., Spertini O., Vey N., Marchand T., Récher C., Pigneux A., Girault S. et al., 2018/12. Haematologica, 103 (12) pp. 2033-2039. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A8F861CC78B6]
Data on a new biomarker for kidney transplant recipients: The number of FoxP3 regulatory T cells in the circulation.
Herrera-Gómez F., Del Aguila W., Tejero-Pedregosa A., Adler M., Padilla-Berdugo R., Maurtua-Briseño-Meiggs Á., Pascual J., Pascual M., San Segundo D., Heidt S. et al., 2018/12. Data in brief, 21 pp. 2567-2575. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0F6AAF8562C2]
 
Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study.
Kuster S., Stampf S., Gerber B., Baettig V., Weisser M., Gerull S., Medinger M., Passweg J., Schanz U., Garzoni C. et al., 2018/12. Transplant infectious disease, 20 (6) pp. e12981. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_14D606BDD623]
 
Long-term outcome of high risk patients with myelodysplastic syndromes or secondary acute myeloid leukemia receiving intensive chemotherapy.
Schuler E., Zadrozny N., Blum S., Schroeder T., Strupp C., Hildebrandt B., Kündgen A., Gattermann N., Aul C., Kondakci M. et al., 2018/12. Annals of hematology, 97 (12) pp. 2325-2332. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D7A4803DB8A5]
 
Proline 36 of the Factor XIII Activation Peptide Plays a Crucial Role in Substrate Recognition and Zymogen Activation.
Li B., Billur R., Maurer M.C., Kohler H.P., Raddatz Müller P., Alberio L., Schroeder V., 2018/12. Thrombosis and haemostasis, 118 (12) pp. 2037-2045. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_07B5E48E31DA]
 
The effect of bariatric surgery on the direct oral anticoagulant rivaroxaban: the extension study.
Kröll D., Nett P.C., Borbély Y.M., Schädelin S., Bertaggia Calderara D., Alberio L., Stirnimann G., 2018/12. Surgery for obesity and related diseases, 14 (12) pp. 1890-1896. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7BA3C904C4DC]
 
Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a report by the French Belgian Swiss APL group (APL 2006 trial).
Rahmé R., Ades L., Thomas X., Guerci-Bresler A., Pigneux A., Vey N., Raffoux E., Castaigne S., Spertini O., Wittnebel S. et al., 2018/11. Haematologica, 103 (11) pp. e519-e521. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9ECB1E4E3ADF]
 
Generation of procoagulant collagen- and thrombin-activated platelets in platelet concentrates derived from buffy coat: the role of processing, pathogen inactivation, and storage.
Bertaggia Calderara D., Crettaz D., Aliotta A., Barelli S., Tissot J.D., Prudent M., Alberio L., 2018/10. Transfusion, 58 (10) pp. 2395-2406. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_35EF9E8EF671]
 
Over 20 years of treatment-free remission after interferon-alpha monotherapy for chronic myeloid leukemia.
Bloch J., Spertini O., Stucki A., Solly F., Blum S., 2018/10. Leukemia research, 73 pp. 103-104. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DA8C4FDC5E5F]
Activation of Bone Marrow-Derived Cells Angiotensin (Ang) II Type 1 Receptor by Ang II Promotes Atherosclerotic Plaque Vulnerability.
Pellegrin M., Bouzourène K., Aubert J.F., Nahimana A., Duchosal M.A., Mazzolai L., 2018/09/04. International journal of molecular sciences, 19 (9) pp. E2621. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DF24A17CD520]
 
The pseudokinase MLKL activates PAD4-dependent NET formation in necroptotic neutrophils.
D'Cruz A.A., Speir M., Bliss-Moreau M., Dietrich S., Wang S., Chen A.A., Gavillet M., Al-Obeidi A., Lawlor K.E., Vince J.E. et al., 2018/09/04. Science signaling, 11 (546) pp. eaao1716. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4D706CFEBE1B]
 
EDTA-related degranulation mimicking Storage Pool Disease.
Amoruso M., Alberio L., Nagy M., 2018/09. American journal of hematology, 93 (9) pp. 1192-1193. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_18D3566A4EF3]
Standardized Management Protocol in Severe Postpartum Hemorrhage: A Single-Center Study.
Colucci G., Helsing K., Biasiutti F.D., Raio L., Schmid P., Tsakiris D.A., Eberle B., Surbek D., Lämmle B., Alberio L., 2018/09. Clinical and applied thrombosis/hemostasis, 24 (6) pp. 884-893. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A175FB499820]
Do hospital doctors test for thrombophilia in patients with venous thromboembolism?
Samim D., Marques-Vidal P., Alberio L., Waeber G., Méan M., 2018/08. Journal of thrombosis and thrombolysis, 46 (2) pp. 238-243. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_66F79DCDACD6]
 
Les lymphohistiocytoses hémophagocytaires [Hemophagocytic Lymphohistiocytosis]
Stalder G., Ribi C., Duchosal M.A., 2018/08. Praxis, 107 (16) pp. 902-911. Peer-reviewed.
[DOI][Pmid][serval:BIB_D46E28896440]
 
Computational design of orthogonal membrane receptor-effector switches for rewiring signaling pathways.
Young M., Dahoun T., Sokrat B., Arber C., Chen K.M., Bouvier M., Barth P., 2018/07/03. Proceedings of the National Academy of Sciences of the United States of America, 115 (27) pp. 7051-7056. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8C56DD9E0F4C]
 
Pseudo Chediak-Higashi anomaly in blasts from acute lymphoblastic leukemia.
Gavillet M., Spertini O., Blum S., 2018/07. Leukemia research, 70 pp. 87-90. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D1FB6B3E560D]
 
Influence of Haemodialysis on Imatinib Plasma Levels in a Case of Philadelphia Positive Acute Lymphoblastic Leukemia
de Goycoechea Diego, Schleyer Eberhard, Naveiras Olaia, Gattermann Norbert, Blum Sabine, 2018/05/25. Annals of Clinical Case Reports.
[serval:BIB_18F02F14B71C]
 
Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
Bello C., Bai J., Zambron B.K., Elías-Rodríguez P., Gajate C., Robina I., Caffa I., Cea M., Montecucco F., Nencioni A. et al., 2018/04/25. European journal of medicinal chemistry, 150 pp. 457-478. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2B525FC316B2]
 
Reply to: The effect of bariatric surgery on direct-acting oral anticoagulant drug levels.
Kröll D., Alberio L., Stirnimann G., 2018/04. Thrombosis research, 164 pp. 15-16. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3A2C4B456F91]
Comment on "MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma".
Voruz S., Martins F., Cairoli A., Naveiras O., Homicsko K., Missiaglia E., de Leval L., Bisig B., Michielin O., Blum S., 2018/03. Haematologica, 103 (3) pp. e130. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0845E1BF99E5]
 
Effect of Rivaroxaban on thrombin generation in vivo. A study in obese patients.
Bertaggia-Calderara D., Kröll D., Gerschheimer C., Nicolas N., Nett P., Stirnimann G., Alberio L., 2018/02. International journal of laboratory hematology, 40 (1) pp. e11-e14. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1406005DBDD1]
 
Improvement of relative survival in elderly patients with acute myeloid leukaemia emerging from population-based cancer registries in Switzerland between 2001 and 2013.
Schnegg-Kaufmann A., Feller A., Baldomero H., Rovo A., Manz M.G., Gregor M., Efthymiou A., Bargetzi M., Hess U., Spertini O. et al., 2018/02. Cancer epidemiology, 52 pp. 55-62. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2CECC2D87623]
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agents.
Cagnetta A., Soncini D., Orecchioni S., Talarico G., Minetto P., Guolo F., Retali V., Colombo N., Carminati E., Clavio M. et al., 2018/01. Haematologica, 103 (1) pp. 80-90. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0A0458D4A8E8]
Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016.
Passweg J.R., Baldomero H., Ansari M., Baerlocher G.M., Bargetzi M., Chalandon Y., Duchosal M.A., Gerull S., Güngör T., Halter J.P. et al., 2018. Swiss medical weekly, 148 pp. w14589. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E2D04A4B0AA3]
Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma.
Voruz S., Cairoli A., Naveiras O., de Leval L., Missiaglia E., Homicsko K., Michielin O., Blum S., 2018/01. Haematologica, 103 (1) pp. e39-e41. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_12A8F7D8B626]
The Role of Plasma Transfusion in Massive Bleeding: Protecting the Endothelial Glycocalyx?
Barelli S., Alberio L., 2018. Frontiers in medicine, 5 p. 91. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_356CFFBE6C41]
2017
 
Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?
Méan M., Limacher A., Stalder O., Angelillo-Scherrer A., Alberio L., Fontana P., Beer H.J., Rodondi N., Lämmle B., Aujesky D., 2017/10. The American journal of medicine, 130 (10) pp. 1220.e17-1220.e22. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9AAA24EFA8D4]
 
Vox Sanguinis International Forum on platelet cryopreservation.
Cohn C.S., Dumont L.J., Lozano M., Marks D.C., Johnson L., Ismay S., Bondar N., T'Sas F., Yokoyama APH, Kutner J.M. et al., 2017/10. Vox sanguinis, 112 (7) pp. e69-e85. Peer-reviewed.
[DOI][Pmid][serval:BIB_12778CF08954]
 
Immunotherapy in adult acute leukemia.
Blum S., Martins F., Lübbert M., 2017/09. Leukemia research, 60 pp. 63-73. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EC3D9761AFA8]
 
Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels.
Studt J.D., Alberio L., Angelillo-Scherrer A., Asmis L.M., Fontana P., Korte W., Mendez A., Schmid P., Stricker H., Tsakiris D.A. et al., 2017/08. Journal of thrombosis and haemostasis, 15 (8) pp. 1576-1583. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A9A3D4C4BE3B]
T315I clone selection in a Ph+ all patient under low-dose ponatinib maintenance.
Noetzli J., Gavillet M., Masouridi-Levrat S., Duchosal M., Spertini O., 2017/08. Clinical case reports, 5 (8) pp. 1320-1322. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F5940E9F0C9D]
 
Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair.
Piacente F., Caffa I., Ravera S., Sociali G., Passalacqua M., Vellone V.G., Becherini P., Reverberi D., Monacelli F., Ballestrero A. et al., 2017/07/15. Cancer research, 77 (14) pp. 3857-3869. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D77736A5EF65]
 
Reversible granulocyte abnormalities after accidental ingestion of Colchicum autumnale.
Kritikos A., Spertini O., 2017/07/06. Blood, 130 (1) p. 95. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1BD5D7825A35]
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders
Orsini Sara, Noris Patrizia, Bury Loredana, Heller Paula G., Santoro Cristina, Kadir Rezan A., Butta Nora C., Falcinelli Emanuela, Cid Ana Rosa, Fabris Fabrizio et al., 2017/07. Haematologica, 102 (7) pp. 1192-1203.
[URN][DOI][WoS][Pmid][serval:BIB_40088583D110]
 
Impact of a product-specific reference standard for the measurement of a PEGylated rFVIII activity: the Swiss Multicentre Field Study.
Bulla O., Poncet A., Alberio L., Asmis L.M., Gähler A., Graf L., Nagler M., Studt J.D., Tsakiris D.A., Fontana P., 2017/07. Haemophilia, 23 (4) pp. e335-e339. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_80FE0E631AD5]
 
Protein modelling to understand FGB mutations leading to congenital hypofibrinogenaemia.
Casini A., Vilar R., Beauverd Y., Aslan D., Devreese K., Mondelaers V., Alberio L., Gubert C., de Moerloose P., Neerman-Arbez M., 2017/07. Haemophilia, 23 (4) pp. 583-589. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_46D3108BBF44]
 
Torque Teno Virus Load and Acute Rejection After Orthotopic Liver Transplantation.
Simonetta F., Pradier A., Masouridi-Levrat S., van Delden C., Giostra E., Morard I., Mueller N., Muellhaupt B., Valli P.V., Semmo N. et al., 2017/07. Transplantation, 101 (7) pp. e219-e221. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8EEBC56CBE4D]
 
Delayed-onset of procoagulant signalling revealed by kinetic analysis of COAT platelet formation.
Alberio L., Ravanat C., Hechler B., Mangin P.H., Lanza F., Gachet C., 2017/06/02. Thrombosis and haemostasis, 117 (6) pp. 1101-1114. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FB7ADCDA152B]
 
Impact of rivaroxaban on point-of-care assays.
Fontana P., Alberio L., Angelillo-Scherrer A., Asmis L.M., Korte W., Mendez A., Schmid P., Stricker H., Studt J.D., Tsakiris D.A. et al., 2017/05. Thrombosis research, 153 pp. 65-70. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1075B3F793FA]
 
Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML.
Löwenberg B., Pabst T., Maertens J., van Norden Y., Biemond B.J., Schouten H.C., Spertini O., Vellenga E., Graux C., Havelange V. et al., 2017/04/23. Blood, 129 (12) pp. 1636-1645. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_04ADFB38F5B5]
Redox Proteomics and Platelet Activation: Understanding the Redox Proteome to Improve Platelet Quality for Transfusion.
Sonego G., Abonnenc M., Tissot J.D., Prudent M., Lion N., 2017/04/11. International journal of molecular sciences, 18 (2) pp. E387.
[URN][DOI][WoS][Pmid][serval:BIB_33AFE8220365]
 
Evolution of body weight parameters up to 3 years after solid organ transplantation: The prospective Swiss Transplant Cohort Study.
Beckmann S., Nikolic N., Denhaerynck K., Binet I., Koller M., Boely E., De Geest S., Psychosocial Interest Group Swiss Transplant Cohort Study, 2017/03. Clinical transplantation, 31 (3). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BA1AD77EB893]
 
Innovative strategies for adverse karyotype acute myeloid leukemia.
Blum S., Greve G., Lübbert M., 2017/03. Current opinion in hematology, 24 (2) pp. 89-98. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CD319BE75546]
 
Nutritional support practices in hematopoietic stem cell transplantation centers: A nationwide comparison.
Baumgartner A., Bargetzi M., Bargetzi A., Zueger N., Medinger M., Passweg J., Schanz U., Samaras P., Chalandon Y., Pichard C. et al., 2017/03. Nutrition, 35 pp. 43-50. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9E75A3B6E6FA]
 
Avancées thérapeutiques dans les maladies rénales associéesaux gammapathies monoclonales [Therapeutic advances in monoclonal gammopathy-associated renal diseases]
Boesch A., Burnier M., Cairoli A., Kissling S., 2017/02/22. Revue medicale suisse, 13 (551) pp. 462-467. Peer-reviewed.
[Pmid][serval:BIB_8EE96736AB0E]
 
Gray platelet syndrome: Novel mutations of the NBEAL2 gene.
Bottega R., Nicchia E., Alfano C., Glembotsky A.C., Pastore A., Bertaggia-Calderara D., Bisig B., Duchosal M.A., Arbesú G., Alberio L. et al., 2017/02. American journal of hematology, 92 (2) pp. E20-E22. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4F5F46E612D6]
 
Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012.
Bonadies N., Feller A., Rovo A., Ruefer A., Blum S., Gerber B., Stuessi G., Benz R., Cantoni N., Holbro A. et al., 2017/02. Cancer epidemiology, 46 pp. 85-92. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4E30164F031A]
 
Pharmacokinetics of lenalidomide during high cut-off dialysis in a patient with multiple myeloma and renal failure.
Dao K., Lu Y., Peer C.J., Figg W.D., Stadelmann R., Burnier M., Buclin T., Kissling S., 2017/01. Cancer chemotherapy and pharmacology, 79 (1) pp. 215-218. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_98ACC5BD24F7]
Rapid immunoassays for diagnosis of heparin-induced thrombocytopenia: Comparison of diagnostic accuracy, reproducibility, and costs in clinical practice.
Bankova A., Andres Y., Horn M.P., Alberio L., Nagler M., 2017. PloS one, 12 (6) pp. e0178289. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CFCE997193FD]
2016
Une leucocytose avec bicytopénie
Jankovic Jeremy, Blum Sabine, 2016/12/06. Forum Médical Suisse ‒ Swiss Medical Forum, 16 (4950).
[URN][DOI][serval:BIB_C68E193B9713]
 
Do we need antiplatelet therapy in thrombocytosis? Pro. Diagnostic and pathophysiologic considerations for a treatment choice.
Alberio L., 2016/11/07. Hamostaseologie, 36 (4) pp. 227-240. Peer-reviewed.
[DOI][Pmid][serval:BIB_1E96A3D68DBB]
 
Une douleur abdominale peu ordinaire ...
Freire Silvia, Vollenweider Peter, Alberio Lorenzo, Gavillet Mathilde, 2016/11/01. Forum Médical Suisse ‒ Swiss Medical Forum, 16 (44).
[DOI][serval:BIB_E69A91CC3C6B]
 
Des céphalées trompeuses
Markopoulou Agni, Grandoni Francesco, Waeber Gérard, Alberio Lorenzo, Gavillet Mathilde, Kraege Vanessa, 2016/10/25. Forum Médical Suisse ‒ Swiss Medical Forum, 16 (43) pp. 921-924. Peer-reviewed.
[DOI][serval:BIB_00D35A695A32]
Temps de thromboplastine partiel activé allongé, que faire?
Aslan Nurullah, Alberio Lorenzo, Blum Sabine, 2016/10/11. Forum Médical Suisse ‒ Swiss Medical Forum, 16 (41).
[URN][DOI][serval:BIB_DCFE859A3A76]
Visceral leishmaniasis in a lung transplant recipient: usefulness of highly sensitive real-time polymerase chain reaction for preemptive diagnosis.
Opota O., Balmpouzis Z., Berutto C., Kaiser-Guignard J., Greub G., Aubert J.D., Prod'hom G., Manuel O., Jaton K., 2016/10. Transplant infectious disease, 18 (5) pp. 801-804. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_930664C96255]
 
Diagnostic et traitement des ischémies mésentériques [Diagnostic and treatment of mesenteric ischemia]
Parliteanu C., Gavillet M., Gié O., Bize P., Maillard M.H., 2016/08/31. Revue medicale suisse, 12 (528) pp. 1419-1423. Peer-reviewed.
[Pmid][serval:BIB_2584F6FE5A1E]
 
Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08.
Hitz F., Zucca E., Pabst T., Fischer N., Cairoli A., Samaras P., Caspar C.B., Mach N., Krasniqi F., Schmidt A. et al., 2016/07. British journal of haematology, 174 (2) pp. 255-263. Peer-reviewed.
[DOI][Pmid][serval:BIB_23BA18C4B4AE]
 
Un purpura d'installation rapide...
de Sans Laura, Bart Pierre-Alexandre, Hohl Daniel, Neub Angela, Alberio Lorenzo, Voruz Sophie, 2016/06/21. Forum Médical Suisse ‒ Swiss Medical Forum, 16 (25).
[DOI][serval:BIB_C3C032DE71C5]
 
Acquired intracoronary ADAMTS13 deficiency and VWF retention at sites of critical coronary stenosis in patients with STEMI.
Pedrazzini G., Biasco L., Sulzer I., Anesini A., Moccetti T., Kremer Hovinga J.A., Alberio L., 2016/06/09. Blood, 127 (23) pp. 2934-2936. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_12184E0D7BAA]
 
Response to correspondence: Flow cytometric quantification of neutrophil extracellular traps: Limitations of the methodological approach by Ciepiela et al.
Williams D.A., Gavillet M., 2016/03. American journal of hematology, 91 (3) pp. E10. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2BA69E18CECE]
 
Une hyperprotéinémie troublante
Beltraminelli Tim, Casutt Giulia, Alberio Lorenzo, Weber Gérard, Sartori Claudio, 2016/01/26. Forum Médical Suisse ‒ Swiss Medical Forum, 16 (04).
[DOI][serval:BIB_C666FCB1E89C]
Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.
Flahaut M., Jauquier N., Chevalier N., Nardou K., Balmas Bourloud K., Joseph J.M., Barras D., Widmann C., Gross N., Renella R. et al., 2016. Bmc Cancer, 16 (1) p. 781. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8AFB2FAA16EB]
 
Effects of oral supplementation of iron on hepcidin blood concentrations among non-anaemic female blood donors: a randomized controlled trial.
Waldvogel S., Rochat B., Peduzzi D., Vaucher P., Tissot J.D., Favrat B., 2016. Vox Sanguinis, 110 (2) pp. 166-171. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D82D2B597632]
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky D.J., Abdelmohsen K., Abe A., Abedin M.J., Abeliovich H., Acevedo Arozena A., Adachi H., Adams C.M., Adams P.D., Adeli K. et al., 2016/01. Autophagy, 12 (1) pp. 1-222.
[URN][DOI][WoS][Pmid][serval:BIB_D1B3A2339998]
Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment.
Gratwohl A., Pfirrmann M., Zander A., Kröger N., Beelen D., Novotny J., Nerl C., Scheid C., Spiekermann K., Mayer J. et al., 2016. Leukemia, 30 (3) pp. 562-569. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E928980A6C80]
Ruxolitinib in the treatment of polycythemia vera: patient selection and special considerations.
Blum S., Martins F., Alberio L., 2016. Journal of Blood Medicine, 7 pp. 205-215. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_AC50BBB0C2BA]
 
Safety and efficacy of cryopreserved autologous platelet concentrates in HLA-alloimmunized patients with hematologic malignancies.
Gerber B., Alberio L., Rochat S., Stenner F., Manz M.G., Buser A., Schanz U., Stussi G., 2016. Transfusion, 56 (10) pp. 2426-2437. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0FBF2C6F7B79]
The J-Curve in HIV: Low and Moderate Alcohol Intake Predicts Mortality but Not the Occurrence of Major Cardiovascular Events.
Wandeler G., Kraus D., Fehr J., Conen A., Calmy A., Orasch C., Battegay M., Schmid P., Bernasconi E., Furrer H. et al., 2016. Journal of Acquired Immune Deficiency Syndromes, 71 (3) pp. 302-309. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_34E20FA8510D]
 
Thromboembolie und Antikoagulation bei Tumorpatienten []
Grandoni F., Kaiser J., Blum S., Alberio L., 2016. Therapeutische Umschau. Revue therapeutique, 73 (10) pp. 595-604. Peer-reviewed.
[DOI][Pmid][serval:BIB_115AB0DBE476]
 
Thromboembolism in patients with congenital afibrinogenaemia. Long-term observational data and systematic review.
Nagler M., Kremer Hovinga J.A., Alberio L., Peter-Salonen K., von Tengg-Kobligk H., Lottaz D., Neerman-Arbez M., Lämmle B., 2016. Thrombosis and Haemostasis, 116 (4) pp. 722-732. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CE4017812B3E]
2015
 
Practical guidelines for Argatroban and Bivalirudin in patients with Heparin-induced Thrombocytopenia.
Colucci G., Nagler M., Klaus N., Conte T., Giabbani E., Alberio L., 2015/09/28. J Translational Science, 1 (2) pp. 37-42. Peer-reviewed.
[DOI][serval:BIB_3456191B0275]
 
“Atypical” macrophages.
Bloch J., Blum S., 2015/04/02. Blood, 125 (14) p. 2305. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_70436B2A16F4]
 
Antiplatelet Therapy and Anticoagulation
Chassot P.G., Barelli S., Blum S., Angelillo-Scherrer A., Marcucci C., 2015. pp. 109-130 dans Perioperative hemostasis chap. 8, Springer.
[DOI][serval:BIB_3447E1DC77BF]
 
Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet.
Lengfelder E., Lo-Coco F., Ades L., Montesinos P., Grimwade D., Kishore B., Ramadan S.M., Pagoni M., Breccia M., Huerta A.J. et al., 2015. Leukemia, 29 (5) pp. 1084-1091. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F673CB37AA8F]
Bases physiopathologiques en hématologie générale : un aide-mémoire d'hématologie
Schmidt P.M., Cornu P., Angelillo-Scherrer A., Abbal C., Jotterand M., Quarroz S., Canham van Dijken P., 2015., Version 17.0, Centre Hospitalier Universitaire Vaudois, Service d'hématologie.
[URN][serval:BIB_9E01B887DB6E]
Basic Physiopathology of General Hematology : a synopsis of hematology.
Schmidt P.M., Cornu P., Angelillo-Scherrer A., Abbal C., Jotterand M., Quarroz S., Canham van Dijken P., 2015., Version 17.0, Centre Hospitalier Universitaire Vaudois, Service d'hématologie.
[URN][serval:BIB_082686F032EC]
 
Cellularity, characteristics of hematopoietic parameters and prognosis in myelodysplastic syndromes.
Schemenau J., Baldus S., Anlauf M., Reinecke P., Braunstein S., Blum S., Nachtkamp K., Neukirchen J., Strup C., Aul C. et al., 2015. European Journal of Haematology, 95 (3) pp. 181-189. Peer-reviewed.
[DOI][Pmid][serval:BIB_433CD5C9496F]
 
Combinative effects of β-Lapachone and APO866 on pancreatic cancer cell death through reactive oxygen species production and PARP-1 activation.
Breton C.S., Aubry D., Ginet V., Puyal J., Heulot M., Widmann C., Duchosal M.A., Nahimana A., 2015. Biochimie, 116 pp. 141-153. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A4DEF65E413F]
Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland
Samaras P., Bargetzi M., Betticher D.C., Duchosal M.A., Heim D., Hess U., Ketterer N., Lerch E., Matthes T., Mey U. et al., 2015. Swiss Medical Weekly, 145 pp. w14100. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0B8C497CD972]
 
Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group.
Braun T., Cereja S., Chevret S., Raffoux E., Beaumont M., Detourmignies L., Pigneux A., Thomas X., Bordessoule D., Guerci A. et al., 2015. Cancer, 121 (14) pp. 2393-2399. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2BB0B5A543B4]
 
Flow cytometric assay for direct quantification of Neutrophil Extracellular Traps in blood samples. : Flow method for NETs detection
Gavillet Mathilde, Martinod Kimberly, Renella Raffaele, Harris Chad, Shapiro Nate I, Wagner Denisa D, Williams David A, 2015. American Journal of Hematology pp. n/a-n/a.
[DOI][serval:BIB_DAAA202C0A72]
 
Formaldehyde-fixation of platelets for flow cytometric measurement of phosphatidylserine exposure is feasible.
Rochat S., Alberio L., 2015. Cytometry. Part A, 87 (1) pp. 32-36. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8E89A4C92EF3]
Hemophagocytic Lymphohistiocytosis and Gastrointestinal Bleeding: What a Surgeon Should Know
Popeskou S., Gavillet M., Demartines N., Christoforidis D., 2015. Case Reports In Surgery, 2015 p. 745848. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_46A59706E382]
 
Pancytopénie avec anémie hémolytique et schizocytes: une approche pragmatique [Pancytopenia, Hemolytic Anemia and Schizocytes: a Pragmatic Approach].
Gökok N., Stalder G., Alberio L., Lamy O., Schwotzer N., 2015. Praxis, 104 (14) pp. 751-754. Peer-reviewed.
[DOI][Pmid][serval:BIB_0EAF9360437A]
Prediction of Post-Weaning Fibrinogen Status during Cardiopulmonary Bypass: An Observational Study in 110 Patients.
Erdoes G., Gerster G., Colucci G., Kaiser H., Alberio L., Eberle B., 2015. Plos One, 10 (5) pp. e0126692. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_58A5D24DFDB5]
 
Progressive Organ Failure After Ingestion of Wild Garlic Juice
Galland-Decker C., Charmoy A., Jolliet P., Spertini O., Hugli O., Pantet O., 2015. Journal of Emergency Medicine, 50 (1) pp. 55-60. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8ED62DEA3ED3]
 
Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia.
Chalandon Y., Thomas X., Hayette S., Cayuela J.M., Abbal C., Huguet F., Raffoux E., Leguay T., Rousselot P., Lepretre S. et al., 2015. Blood, 125 (24) pp. 3711-3719. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9946CDF20155]
 
Syndromes myélodysplasiques et auto-immunité [Myelodysplastic syndromes and autoimmunity].
Stalder G., Alberio L., Ribi C., 2015. Revue Médicale Suisse, 11 (469) pp. 820-2, 824-5.
[Pmid][serval:BIB_2652D42C3E88]
The potential use of microcalorimetry in rapid differentiation between septic arthritis and other causes of arthritis.
Yusuf E., Hügle T., Daikeler T., Voide C., Borens O., Trampuz A., 2015. European Journal of Clinical Microbiology and Infectious Diseases, 34 (3) pp. 461-465. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_5BF1478F41A8]
2014
A critical role of autophagy in antileukemia/lymphoma effects of APO866, an inhibitor of NAD biosynthesis.
Ginet V., Puyal J., Rummel C., Aubry D., Breton C., Cloux A.J., Majjigapu S.R., Sordat B., Vogel P., Bruzzone S. et al., 2014. Autophagy, 10 (4) pp. 603-617.
[URN][DOI][WoS][Pmid][serval:BIB_E0EC16EEBAEC]
A novel anti-CD19 monoclonal antibody (GBR 401) with high killing activity against B cell malignancies.
Breton C.S., Nahimana A., Aubry D., Macoin J., Moretti P., Bertschinger M., Hou S., Duchosal M.A., Back J., 2014. Journal of Hematology and Oncology, 7 p. 33. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_01E6AE78E68F]
 
Azacytidine for acute myeloid leukemia in elderly or frail patients: a phase II trial (SAKK 30/07).
Passweg J.R., Pabst T., Blum S., Bargetzi M., Li Q., Heim D., Stussi G., Gregor M., Leoncini L., Meyer-Monard S. et al., 2014. Leukemia and Lymphoma, 55 (1) pp. 87-91.
[DOI][WoS][Pmid][serval:BIB_EFBD423076BB]
Bases physiopathologiques en hématologie générale : un aide-mémoire d'hématologie
Schmidt P.M., Cornu P., Angelillo-Scherrer A., Abbal C., Cairoli A., Jotterand M., Quarroz S., Canham van Dijken P., 2014., Version 16.0, Centre Hospitalier Universitaire Vaudois, Service d'hématologie.
[URN][serval:BIB_45E22AB249D5]
Basic Physiopathology of General Hematology : a synopsis of hematology
Schmidt P.M., Cornu P., Angelillo-Scherrer A., Abbal C., Cairoli A., Jotterand M., Quarroz S., Canham van Dijken P., 2014., Version 16.0, Centre Hospitalier Universitaire Vaudois, Service d'hématologie.
[URN][serval:BIB_291B55BD90E4]
 
Bilateral periorbital ecchymoses. An often missed sign of amyloid purpura.
Colucci G., Alberio L., Demarmels Biasiutti F., Lämmle B., 2014. Hämostaseologie, 34 (3) pp. 249-252. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E8C94D970BD1]
Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial.
Gotta V., Widmer N., Decosterd L.A., Chalandon Y., Heim D., Gregor M., Benz R., Leoncini-Franscini L., Baerlocher G.M., Duchosal M.A. et al., 2014. Cancer Chemotherapy and Pharmacology, 74 (6) pp. 1307-1319. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8EFC5835C440]
Conjunctival MALT lymphoma: utility of FDG PET/CT for diagnosis, staging, and evaluation of treatment response.
Sallak A., Besson F.L., Pomoni A., Christinat A., Adler M., Aegerter J.P., Nguyen C., de Leval L., Frossard V., Prior J.O., 2014. Clinical Nuclear Medicine, 39 (3) pp. 295-297.
[URN][DOI][WoS][Pmid][serval:BIB_009F834B565E]
 
High-dose therapy and autologous hematopoietic stem cell transplant in T-cell lymphoma: a single center experience.
Cairoli A., Ketterer N., Barelli S., Duchosal M.A., 2014. Leukemia and Lymphoma, 55 (8) pp. 1827-1831.
[DOI][WoS][Pmid][serval:BIB_B5FB5BD9936B]
 
The anti-lymphoma activity of APO866, an inhibitor of nicotinamide adenine dinucleotide biosynthesis, is potentialized when used in combination with anti-CD20 antibody.
Nahimana A., Aubry D., Breton C.S., Majjigapu S.R., Sordat B., Vogel P., Duchosal M.A., 2014. Leukemia and Lymphoma, 55 (9) pp. 2141-2150.
[DOI][WoS][Pmid][serval:BIB_8DB096080B48]
The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates.
Kaiser-Guignard J., Canellini G., Lion N., Abonnenc M., Osselaer J.C., Tissot J.D., 2014. Blood Reviews, 28 (6) pp. 235-241. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0DF65F1D66D1]
 
The influence of drugs used in cardiac anaesthesia and critical care on multiple electrode aggregometry: an in-vitro volunteer study.
Morisoli A.P., Gronchi F., Ferrari E., Blanc C., Frascarolo P., Angelillo-Scherrer A., Marcucci C., 2014. European Journal of Anaesthesiology, 31 (9) pp. 499-504. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8558264FE468]
 
The new direct oral anticoagulants in special indications: rationale and preliminary data in cancer, mechanical heart valves, anti-phospholipid syndrome, and heparin-induced thrombocytopenia and beyond.
Alberio L., 2014. Seminars in Hematology, 51 (2) pp. 152-156. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_196387084CAF]
 
Validation of the revised international prognostic scoring system (IPSS-R) in patients with myelodysplastic syndrome: a multicenter study.
Neukirchen J., Lauseker M., Blum S., Giagounidis A., Lübbert M., Martino S., Siragusa S., Schlenk R.F., Platzbecker U., Hofmann W.K. et al., 2014. Leukemia Research, 38 (1) pp. 57-64. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2CC848AADF0C]
2013
 
Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism.
Scherz N., Méan M., Limacher A., Righini M., Jaeger K., Beer H.J., Frauchiger B., Osterwalder J., Kucher N., Matter C.M. et al., 2013/03. Journal of thrombosis and haemostasis, 11 (3) pp. 435-443. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4178C8EA42ED]
A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A.
Lane J., McLaren P.J., Dorrell L., Shianna K.V., Stemke A., Pelak K., Moore S., Oldenburg J., Alvarez-Roman M.T., Angelillo-Scherrer A. et al., 2013. Human Molecular Genetics, 22 (9) pp. 1903-1910.
[URN][DOI][WoS][Pmid][serval:BIB_274A16CCE410]
 
Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT.
Jantunen E., Boumendil A., Finel H., Luan J.J., Johnson P., Rambaldi A., Haynes A., Duchosal M.A., Bethge W., Biron P. et al., 2013. Blood, 121 (13) pp. 2529-2532.
[DOI][WoS][Pmid][serval:BIB_5E31A5BEE4AD]
Bases physiopathologiques en hématologie générale : un aide-mémoire d'hématologie
Schmidt P.M., Cornu P., Angelillo-Scherrer A., Quarroz S., Parlier V., Canham van Dijken P., 2013., Version 15.0, Centre Hospitalier Universitaire Vaudois, Service d'hématologie.
[URN][serval:BIB_FEB5047B3E5F]
Basic Physiopathology of General Hematology : a synopsis of hematology
Schmidt P.M., Cornu P., Angelillo-Scherrer A., Quarroz S., Parlier V., Canham van Dijken P., 2013., Version 15.0, Centre Hospitalier Universitaire Vaudois, Service d'hématologie.
[URN][serval:BIB_49D174C40D74]
 
Blood microvesicles: from proteomics to physiology
Tissot J.D., Canellini G., Rubin O., Angelillo-Scherrer A., Delobel J., Prudent M., Lion N., 2013. Translational Proteomics, 1 (1) pp. 38-52.
[URN][DOI][serval:BIB_ED95246059FD]
 
Clinical pharmacokinetics of imatinib and its therapeutic relevance
Widmer N., Gotta V., Haouala A., Blanc J., von Mehren M., Duchosal M., Leyvraz S., Csajka C., Decosterd L.A., Buclin T., 2013. pp. 15-43 dans Akhtari M., Elhemaidi I. (eds.) Imatinib: Chemical structure, pharmacology and adverse effects chap. 2, Nova Science Publishers.
[serval:BIB_4D7D4CB0B535]
 
Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: Results from the randomized controlled I-COME Trial
Gotta V., Widmer N., Decosterd L.A., Chalandon Y., Heim D., Benz R., Gregor M., Leoncini-Franscini L., Baerlocher G., Duchosal M. et al., 2013. pp. e6 dans 11th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Clinical Therapeutics. Peer-reviewed.
[DOI][serval:BIB_950BDE93EF84]
 
Development of a Selective Peptide Macrocycle Inhibitor of Coagulation Factor XII toward the Generation of a Safe Antithrombotic Therapy.
Baeriswyl V., Calzavarini S., Gerschheimer C., Diderich P., Angelillo-Scherrer A., Heinis C., 2013. Journal of Medicinal Chemistry, 56 (9) pp. 3742-3746.
[DOI][WoS][Pmid][serval:BIB_73BC92D2A3DA]
 
EBV+ cutaneous B-cell lymphoproliferation of the leg in an elderly patient with mycosis fungoides and methotrexate treatment.
Rausch T., Cairoli A., Benhattar J., Spring P., Hohl D., de Leval L., 2013. Apmis : Acta Pathologica, Microbiologica, et Immunologica Scandinavica, 121 (1) pp. 79-84.
[DOI][WoS][Pmid][serval:BIB_6E23C360E8C8]
Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries.
Passweg J.R., Baldomero H., Bargetzi M., Bucher C., Chalandon Y., Duchosal M.A., Gratwohl A., Güngör T., Hess U., Leibundgut K. et al., 2013. Swiss Medical Weekly, 143 (143) pp. w13757.
[URN][DOI][Pmid][serval:BIB_A10CE93BD13E]
 
Long-term follow-up of European APL 2000 trial, evaluating the role of cytarabine combined with ATRA and Daunorubicin in the treatment of nonelderly APL patients.
Adès L., Chevret S., Raffoux E., Guerci-Bresler A., Pigneux A., Vey N., Lamy T., Huguet F., Vekhoff A., Lambert J.F. et al., 2013. American Journal of Hematology, 88 (7) pp. 556-559. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6C493471C7AC]
 
Myélome multiple : diagnostic et perspectives thérapeutiques
Cairoli A., Duchosal M.A., 2013. Swiss Medical Forum = Forum Médical Suisse, 13 (38) pp. 746-751.
[serval:BIB_E4BAF42E1257]
 
Questions et réponses sur l'utilisation du rivaroxaban (Xarelto) dans la pratique [Questions and answers regarding the use of rivaroxaban in daily practice].
groupe de travail RivaMoS Suisse, groupe Working Party on Haemostasis de la Société suisse d'hématologie, 2013. Revue Médicale Suisse, 9 (392) pp. 1375-1385. Peer-reviewed.
[Pmid][serval:BIB_211D237D6A6D]
 
Red blood cell-derived microparticles isolated from blood units initiate and propagate thrombin generation.
Rubin O., Delobel J., Prudent M., Lion N., Kohl K., Tucker E.I., Tissot J.D., Angelillo-Scherrer A., 2013. Transfusion, 53 (8) pp. 1744-1754.
[DOI][WoS][Pmid][serval:BIB_EC8284C97B27]
Variability between laboratories performing coagulation tests with identical platforms: a nationwide evaluation study.
Nagler M., Bachmann L.M., Alberio L., Angelillo-Scherrer A., Asmis L.M., Korte W., Mendez A., Reber G., Stricker H., Tsakiris D.A. et al., 2013. Thrombosis Journal, 11 (1) p. 6. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B2A91169F7A2]
2012
Transfusion independence and survival in patients with acute myeloid leukemia treated with 5-azacytidine.
Gavillet M., Noetzli J., Blum S., Duchosal M.A., Spertini O., Lambert J.F., 2012/12. Haematologica, 97 (12) pp. 1929-1931. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B9132A398C21]
 
Neutropenie und Fieber unklarer Genese [Neutropenia and fever of unknown origin]
Gavillet M., Medinger M., Tichelli A., Fux-Arnold C., 2012/11/28. Praxis, 101 (24) pp. 1573-1576. Peer-reviewed.
[DOI][Pmid][serval:BIB_9E995F5665D4]
 
Guidelines for the use and interpretation of assays for monitoring autophagy.
Klionsky D.J., Abdalla F.C., Abeliovich H., Abraham R.T., Acevedo-Arozena A., Adeli K., Agholme L., Agnello M., Agostinis P., Aguirre-Ghiso J.A. et al., 2012/04. Autophagy, 8 (4) pp. 445-544. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_56859EA53CC8]
 
A critical review of the molecular pathophysiology of lenalidomide sensitivity in 5q - myelodysplastic syndromes.
Voutsadakis I.A., Cairoli A., 2012. Leukemia and Lymphoma, 53 (5) pp. 779-788.
[DOI][WoS][Pmid][serval:BIB_7F19DEDF7765]
 
Acute coronary syndrome upon receiving carmustine infusion before autologous stem-cell transplantation.
Waibel Pachinger C., Rosselet A., Berthouzoz S., Luthi F., Ketterer N., 2012. Hematological Oncology, 30 (4) pp. 216-218.
[DOI][WoS][Pmid][serval:BIB_1A4AFF9B477E]
 
Autologous Stem Cell Transplantation (ASCT) for Enteropathy-Associated T-Cell Lymphoma (EATL): Final Analysis of a Retrospective Study On the Behalf of Lymphoma Working Party (LWP) of the European Group for Blood and Marrow Transplantation (EBMT).
Jantunen E., Boumendil A., Finel H., Luan J.J., Johnson P.R.E, Rambaldi A., Haynes A., Duchosal M.A., Kanz L., Biron P. et al., 2012. pp. Abstract 3105 dans ASH 2012, 54th Annual Meeting of the American Society of Hematology, Blood.
[WoS][serval:BIB_31C35B035C8D]
Bases physiopathologiques en hématologie générale : un aide-mémoire d'hématologie
Schmidt P.M., Cornu P., Angelillo-Scherrer A., Quarroz S., Parlier V., Canham van Dijken P., 2012., Version 14.0, Centre Hospitalier Universitaire Vaudois, Service d'hématologie.
[URN][serval:BIB_F0C39D916E29]
Basic Physiopathology of General Hematology : a synopsis of hematology
Schmidt P.M., Cornu P., Angelillo-Scherrer A., Quarroz S., Parlier V., Canham van Dijken P., 2012., Version 14.0, Centre Hospitalier Universitaire Vaudois, Service d'Hématologie.
[URN][serval:BIB_04F301AD1DB7]
 
Block of red blood cell maturation in acute erythroid leukemia.
Blum S., Angelillo-Scherrer A., 2012. Blood, 120 (10) p. 1974.
[WoS][Pmid][serval:BIB_2FFF00CCEAD9]
 
Catastrophic Complications of Intravenous Line Flushing with Unfractionated Heparin
Colucci Giuseppe, Jahns Maximilian, Silzle Tobias, Alberio Lorenzo, 2012. International Journal of Clinical Medicine, 03 (01) pp. 36-39.
[DOI][serval:BIB_C20E523E2A64]
 
Chronic idiopathic urticaria successfully treated by anticoagulant drugs.
Spring P., Angelillo-Scherrer A., Bigliardi P., 2012. European Journal of Dermatology, 22 (6) pp. 788-790.
[DOI][WoS][Pmid][serval:BIB_95D5408DF19A]
 
Ezrin-Radixin-Moesin-binding Sequence of PSGL-1 Glycoprotein Regulates Leukocyte Rolling on Selectins and Activation of Extracellular Signal-regulated Kinases.
Spertini C., Baïsse B., Spertini O., 2012. Journal of Biological Chemistry, 287 (13) pp. 10693-10702. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2E009BDCF43C]
Gammapathies monoclonales: Utilisation des chaînes légères libres sériques.
Aubert V., Duchosal M.A., 2012. Swiss Medical Forum, 12 (29) pp. 576-577.
[URN][serval:BIB_35719C47A1D5]
 
Identification of in vitro HSC fate regulators by differential lipid raft clustering.
Vannini N., Roch A., Naveiras O., Griffa A., Kobel S., Lutolf M.P., 2012. Cell Cycle, 11 (8) pp. 1535-1543. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F9B88A4797BA]
 
In Vivo Modulation of Mitochondrial Activity Determines HSC Engraftment and Post-Transplant Survival in Mice
Vannini N., Naveiras O.M., Campos V., Pirinen E., Houtkooper R., Girotra M., Roch A., Auwerx J., Lutolf M., 2012. pp. Abstract 213 dans ASH 2012, 54th Annual Meeting of the American Society of Hematology, Blood.
[WoS][serval:BIB_3520FE74877B]
 
Pharmacokinetic (PK)-based dosage individualization of imatinib: evaluation of efficiency and clinical usefulness
Gotta V., Widmer N., Decosterd L.A., Montemurro M., Leyvraz S., Chalandon Y., Heim D., Gregor M., Benz R., Leoncini-Franscini L. et al., 2012. dans 3rd Symposium of the Swiss Clinical Trial Organisation (SCTO), Personalised Medicine in Clinical Research.
[serval:BIB_10F3BBD6809D]
 
Prospective comparison of clinical prognostic scores in elderly patients with pulmonary embolism.
Zwierzina D., Limacher A., Méan M., Righini M., Jaeger K., Beer H.J., Frauchiger B., Osterwalder J., Kucher N., Matter C.M. et al., 2012. Journal of Thrombosis and Haemostasis, 10 (11) pp. 2270-2276. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F6088F1A4521]
 
Quantification of the anticoagulatory effect of novel anticoagulants and management of emergencies
Gavillet M., Angelillo-Scherrer A., 2012. Médecine Cardiovasculaire = Kardiovaskuläre Medizin = Cardiovascular Medicine, 15 (5) pp. 170-179.
[serval:BIB_2D4474017435]
 
Rivaroxaban: Quantification by anti-FXa assay and influence on coagulation tests: a study in 9 Swiss laboratories.
Asmis L.M., Alberio L., Angelillo-Scherrer A., Korte W., Mendez A., Reber G., Seifert B., Stricker H., Tsakiris D.A., Wuillemin W.A., 2012. Thrombosis Research, 129 (4) pp. 492-498. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_45EF032BD7EE]
 
Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter study.
Germing U., Lauseker M., Hildebrandt B., Symeonidis A., Cermak J., Fenaux P., Kelaidi C., Pfeilstöcker M., Nösslinger T., Sekeres M. et al., 2012. Leukemia, 26 (6) pp. 1286-1292.
[DOI][WoS][Pmid][serval:BIB_3715D1EBA05D]
 
Targeting PI3KC2β Impairs Proliferation and Survival in Acute Leukemia, Brain Tumours and Neuroendocrine Tumours.
Boller D., Doepfner K.T., DE Laurentiis A., Guerreiro A.S., Marinov M., Shalaby T., Depledge P., Robson A., Saghir N., Hayakawa M. et al., 2012. Anticancer Research, 32 (8) pp. 3015-3027.
[WoS][Pmid][serval:BIB_CD36CE57F3C8]
Using digital RNA counting and flow cytometry to compare mRNA with protein expression in acute leukemias.
Fernandez P., Solenthaler M., Spertini O., Quarroz S., Rovo A., Lovey P.Y., Leoncini L., Ruault-Jungblut S., D'Asaro M., Schaad O. et al., 2012. Plos One, 7 (11) pp. e49010. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FE015794D466]
2011
Traitement et prophylaxie de la Maladie ThromboEmbolique Veineuse (MTEV)
Centre hospitalier universitaire vaudois, Policlinique médicale universitaire (Lausanne) , 2011/05. 2 p..
[URN][serval:BIB_EFE579EC6162]
Mise en place percutanée de filtres dans la veine cave inférieure en prévention de l'embolie pulmonaire : recommandations
Mazzolai L., Qanadli S., 2011/04. 7 p..
[URN][serval:BIB_D67D89778302]
A novel potent Fas agonist for selective depletion of tumor cells in hematopoietic transplants
Nahimana A., Aubry D., Lagopoulos L., Greaney P., Attinger A., Demotz S., Dawson K.M., Schapira M., Tschopp J., Dupuis M. et al., 2011. Blood Cancer Journal, 1 (12) pp. e47.
[URN][DOI][WoS][serval:BIB_F400AD0C819E]
 
A sensitized RNA interference screen identifies a novel role for the PI3K p110γ isoform in medulloblastoma cell proliferation and chemoresistance.
Guerreiro A.S., Fattet S., Kulesza D.W., Atamer A., Elsing A.N., Shalaby T., Jackson S.P., Schoenwaelder S.M., Grotzer M.A., Delattre O. et al., 2011. Molecular Cancer Research, 9 (7) pp. 925-935.
[DOI][WoS][Pmid][serval:BIB_628C6340325C]
 
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols.
Bello C., Dal Bello G., Cea M., Nahimana A., Aubry D., Garuti A., Motta G., Moran E., Fruscione F., Pronzato P. et al., 2011. Bioorganic and Medicinal Chemistry, 19 (24) pp. 7720-7727.
[DOI][WoS][Pmid][serval:BIB_516406B5E329]
Bases physiopathologiques en hématologie générale : un aide-mémoire d'hématologie
Schmidt P.M., Cornu P., Angelillo-Scherrer A., Quarroz S., Canham van Dijken P., 2011., Version 13.0, Centre Hospitalier Universitaire Vaudois, Service d'hématologie.
[URN][serval:BIB_41315]
 
Connexin 37 limits thrombus propensity by downregulating platelet reactivity.
Angelillo-Scherrer A., Fontana P., Burnier L., Roth I., Sugamele R., Brisset A., Morel S., Nolli S., Sutter E., Chassot A. et al., 2011. Circulation, 124 (8) pp. 930-939.
[DOI][WoS][Pmid][serval:BIB_2BE789B05435]
 
Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib.
Haouala A., Widmer N., Duchosal M.A., Montemurro M., Buclin T., Decosterd L.A., 2011. Blood, 117 (8) pp. e75-e87. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E62C33C9D4C7]
 
Follicular lymphoma at relapse after rituximab containing regimens: comparison of time to event intervals prior to and after (90) Y-ibritumomab-tiuxetan.
Cicone F., Russo E., Carpaneto A., Prior J.O., Delaloye A.B., Scopinaro F., Ketterer N., 2011. Hematological Oncology, 29 (3) pp. 131-138.
[DOI][WoS][Pmid][serval:BIB_9DAD44467A9D]
 
Frequency of platelet type versus type 2B von Willebrand disease. An international registry-based study.
Hamilton A., Ozelo M., Leggo J., Notley C., Brown H., Frontroth J.P., Angelillo-Scherrer A., Baghaei F., Enayat S.M., Favaloro E. et al., 2011. Thrombosis and Haemostasis, 105 (3) pp. 501-508.
[DOI][WoS][Pmid][serval:BIB_1144945020E6]
 
Growth arrest-specific gene 6 (GAS6) as an intra-hospital mortality predictor for patients in septic shock
Stalder G., Kosinski C., Delodder F., Ternon B., Roger T., Calandra T., Duchosal M.A., Eggimann P., Angelillo-Scherrer A., 2011. p. 14 dans ISTH 2011, 23rd Congress of the International Society on Thrombosis and Haemostasis, 57th Annual SSC Meeting (Scientific and Standardization Committee), Journal of Thrombosis and Haemostasis. Peer-reviewed.
[WoS][serval:BIB_61DF0559A106]
Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q.
Mallo M., Cervera J., Schanz J., Such E., García-Manero G., Luño E., Steidl C., Espinet B., Vallespí T., Germing U. et al., 2011. Leukemia, 25 (1) pp. 110-120. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BD04315DCC0E]
 
Insight in protein S deficiency from mouse models
Calzavarini S., Saller F., Fernandez J.A., Kadi L., Brisset A.C., Burnier L., Azevedo M., Ternon B., Griffin J.H., Angelillo-Scherrer A., 2011. pp. Abstract 529 dans 2011 American Society of Hematologie (ASH) 53rd Annual Meeting, Blood. Peer-reviewed.
[serval:BIB_ACFE9C7B53A7]
 
Leukoagglutination reported as platelet clumps
Grob A. V., Angelillo-Scherrer A., 2011. Blood, 118 (11) p. 2940. Peer-reviewed.
[DOI][WoS][serval:BIB_B4482C2B709E]
Life-threatening bleeding under vitamin K antagonists in spite of an INR in the therapeutic range.
Gavillet M., Abbal C., Schmidt S., Nötzli J., Lambert J.F., Angelillo-Scherrer A., 2011. Journal of Thrombosis and Thrombolysis, 32 (2) pp. 232-237.
[URN][DOI][WoS][Pmid][serval:BIB_7C767BD2C680]
 
Partager la vie : témoignages
Pascual M., 2011. pp. 160-173 dans Schneider P., Tissot J.D., Benzoni M., Ribes O. (eds.) Le sang : Arts, Sciences, Vie, Favre.
[serval:BIB_6C7DBA8191A7]
 
Pathogenèse des maladies cardiovasculaires chez les patients infectés par le VIH: un big bang encore non élucidé [Controversies regarding the pathogenesis of cardiovascular diseases in HIV patients].
Barelli S., Angelillo-Scherrer A., Foguena A.K., Periard D., Cavassini M., 2011. Revue Médicale Suisse, 7 (292) pp. 905-910.
[Pmid][serval:BIB_A005FD3220D9]
Recommendations pour le diagnostic et le traitement de la leucémie lymphoïde chronique en Suisse. 1ère partie : Diagnostic, stadification et facteurs pronostiques
Gregor M., Bargetzi M., Duchosal M.A., Goede J.S., Heim D., Helg C., Korte W., Leoncini L., Solenthaler M., Zenhäusern R., 2011. Forum Médical Suisse, 11 (6) pp. 93-97.
[URN][serval:BIB_BC342385AC68]
Recommendations pour le diagnostic et le traitement de la leucémie lymphoïde chronique en Suisse. 2ème partie : Indications et stratégies thérapeutiques
Gregor M., Bargetzi M., Duchosal M.A., Goede J.S., Heim G., Helg C., Korte W., Leoncini L., Solenthaler M., Zenhäusern R., 2011. Forum Médical Suisse, 11 (7) pp. 118-124.
[URN][serval:BIB_D8DA44554150]
 
The GAP junction protein connexin37 regulates FVIII plasmatic activity
Burnier L., Fontana P., Kwak B.R., Angelillo-Scherrer A., 2011. p. 32 dans 23rd Congress of the International Society on Thrombosis and Haemostasis, 57th Annual SSC Meeting, Journal of Thrombosis and Haemostasis. Peer-reviewed.
[WoS][serval:BIB_E01AD39C6BDA]
 
Thrombophilie: investiguer ou ne pas investiguer [Thrombophilia: is there a need to investigate?].
Méan M., Angelillo-Scherrer A., 2011. Revue Médicale Suisse, 7 (294) pp. 1025-1027.
[Pmid][serval:BIB_608CBBDAD937]
2010
Hematopoietic stem cell transplantation in Switzerland: a comprehensive quality control report on centre effect.
Passweg J., Baldomero H., Stern M., Bargetzi M., Ghielmini M., Leibundgut K., Duchosal M., Hess U., Seger R., Buhrfeind E. et al., 2010/06/12. Swiss medical weekly, 140 (23-24) pp. 326-334. Peer-reviewed.
[URN][WoS][Pmid][serval:BIB_B58A6E60AD2B]
 
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies.
Bello C., Cea M., Dal Bello G., Garuti A., Rocco I., Cirmena G., Moran E., Nahimana A., Duchosal M.A., Fruscione F. et al., 2010/05/01. Bioorganic & medicinal chemistry, 18 (9) pp. 3320-3334. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FE0F7F1D0119]
Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability.
Allaman I., Gavillet M., Bélanger M., Laroche T., Viertl D., Lashuel H.A., Magistretti P.J., 2010/03/03. The Journal of neuroscience, 30 (9) pp. 3326-3338. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D1311F834070]
 
Chemotherapy is successful in sporadic late onset nemaline myopathy (SLONM) with monoclonal gammopathy.
Novy J., Rosselet A., Spertini O., Lobrinus J.A., Pabst T., Kuntzer T., 2010/02. Muscle & nerve, 41 (2) pp. 286-287. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_864F3EA6F2FD]
 
5-Azacytidine to Treat Acute Myeloid Leukemia In Elderly or Frail Patients: A Phase II Study (SAKK 30/07).
Passweg J.R., Pabst T., Blum S., Bargetzi M., Sun H., Heim D., Stussi G., Gregor M., Leoncini L., Meyer-Monard S. et al., 2010. p. 900 dans 52nd Annual Meeting of the American Society of Hematology (ASH), Blood.
[WoS][serval:BIB_85F59D630C8B]
 
Absence of residual Hodgkin's disease demonstrated by PET/CT in a deceased organ donor.
Prior J.O., Duchosal M.A., Schmidt S., Turini P., Pilon N., Chioléro R., Pascual M., 2010/01. Transplant international, 23 (1) pp. 101-104. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9C57AF25D17D]
 
Acute myeloid leukemia with myeloid sarcoma and eosinophilia: prolonged remission and molecular response to imatinib.
Vedy Dana, Muehlematter Dominique, Rausch Thierry, Stalder Michele, Jotterand Martine, Spertini Olivier, 2010. Journal of Clinical Oncology, 28 (3) pp. e33-55.
[DOI][WoS][Pmid][serval:BIB_E51BF38E903E]
 
Coagulation Factor Xa Activates Thrombin and Signals Ischemic Neuronal Death Via Par-1 and JNK in Ischemic Neural Tissue
Thevenet J., Angelillo-Scherrer A., Badaut J., Price M., Hirt L., 2010. p. 315 dans 19th European Stroke Conference, Cerebrovascular Diseases. Peer-reviewed.
[serval:BIB_C136EA470F9A]
 
Cooperative expression of junctional adhesion molecule-C and -B supports growth and invasion of glioma.
Tenan M., Aurrand-Lions M., Widmer V., Alimenti A., Burkhardt K., Lazeyras F., Belkouch M.C., Hammel P., Walker P.R., Duchosal M.A. et al., 2010. Glia, 58 (5) pp. 524-537. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_19D881C05D13]
 
Diagnostic et prise en charge de la thrombocytopénie immune primaire
Keller P., Angelillo-Scherrer A., Bargetzi M., Goede J., Hess U., Imbach P., Kühne T., Mach-pascual S., Mey U., Rüfer A. et al., 2010. Swiss Medical Forum = Forum Médical Suisse, 10 (50) pp. 875-883.
[serval:BIB_3C7BE9A3A52E]
 
Feasibility of Therapeutic Drug Monitoring (TDM) for Imatinib: Preliminary considerations on the dosage adjustment approach for CML patients enrolled in the Imatinib Concentration Monitoring (I-COME) study
Gotta V., Widmer N., Decosterd L.A., Csajka C., Duchosal M.A., Chalandon Y., Heim D., Gregor M., Buclin T., 2010. pp. 90S dans 78. Jahresversammlung der Schweizerischen Gesellschaft für Innere Medizin, Swiss Medical Forum = Forum Médical Suisse. Peer-reviewed.
[serval:BIB_FCE60B11AFF2]
 
Gas6 deficiency in recipient mice of allogeneic transplantation alleviates hepatic graft-versus-host disease.
Burnier L., Saller F., Kadi L., Brisset A.C., Sugamele R., Baudino L., Bono F., Herbert J.M., Carmeliet P., Schapira M. et al., 2010. Blood, 115 (16) pp. 3390-3397.
[DOI][WoS][Pmid][serval:BIB_923C5E3D1305]
 
Geoepidemiology of autoimmune hemolytic anemia.
Lambert Jean-Francois, Nydegger Urs E., 2010. Autoimmunity Reviews, 9 (5) pp. 350-354.
[DOI][WoS][Pmid][serval:BIB_DAB819C3591C]
 
Potentiating role of Gas6 and Tyro3, Axl and Mer (TAM) receptors in human and murine platelet activation and thrombus stabilization.
Cosemans J.M., Van Kruchten R., Olieslagers S., Schurgers L.J., Verheyen F.K., Munnix I.C., Waltenberger J., Angelillo-Scherrer A., Hoylaerts M.F., Carmeliet P. et al., 2010. Journal of Thrombosis and Haemostasis : Jth, 8 (8) pp. 1797-1808.
[DOI][WoS][Pmid][serval:BIB_C7838D7ABE6C]
 
Recommendations for the diagnosis and treatment of myelodysplastic syndromes in adult patients in Switzerland
Passweg J.R., Duchosal M.A., Hess U., Blum S., Freiburghaus A.U., Bargetzi M., Binder D., Dirnhofer St., Friess D., Goede J.S. et al., 2010. Swiss Medical Forum = Forum Médical Suisse, 10 (15) pp. 259-265.
[serval:BIB_D1F2EAA2AB70]
 
Recurrent postpartum cerebral sinus vein thrombosis as a presentation of cystathionine-beta-synthase deficiency.
Novy J., Ballhausen D., Bonafé L., Cairoli A., Angelillo-Scherrer A., Bachmann C., Michel P., 2010. Thrombosis and Haemostasis, 103 (4) pp. 871-873.
[DOI][WoS][Pmid][serval:BIB_151897DB36DD]
Suivi thérapeutique de l'imatinib
Gotta V., Widmer N., Decosterd L.A., Csajka C., Duchosal M.A., Chalandon Y., Heim D., Gregor M., Buclin T., 2010. Forum Medical Suisse, 10 (23) pp. 403-406. Peer-reviewed.
[URN][serval:BIB_FE549E7D44DF]
Treatment of 5q-syndrome with lenalidomide in an HIV-positive patient under cART.
Blum Sabine, Cavassini Matthias, Lambert Jean-Francois, Fayet Aurelie, Schapira Marc, Jotterand Martine, 2010. Annals of Hematology, 89 (4) pp. 425-426.
[URN][DOI][WoS][Pmid][serval:BIB_6513BEF5AFEB]
 
Une dyspnée pas comme les autres, ou quand on parle du loup.. [Unusual cause for a dyspnea.].
Gavillet Mathilde, Maillard Dewarrat G., Petitpierre S., Vollenweider Peter, 2010. Praxis, 99 (19) pp. 1157-1162.
[DOI][Pmid][serval:BIB_7E642AC90591]
 
Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial.
de Witte T., Hagemeijer A., Suciu S., Belhabri A., Delforge M., Kobbe G., Selleslag D., Schouten H.C., Ferrant A., Biersack H. et al., 2010. Haematologica, 95 (10) pp. 1754-1761.
[DOI][WoS][Pmid][serval:BIB_1BB03EB51B01]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University